Insufficient scRNA-seq data for expression of IFNA17 at single-cell level.
Insufficient scRNA-seq data for expression of IFNA17 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 10% | 0.56 | 9 / 89 | 0% | 0 | 0 / 901 |
bladder | 10% | 0.19 | 2 / 21 | 0% | 0 | 0 / 504 |
brain | 9% | 0.18 | 226 / 2642 | 0% | 0 | 0 / 705 |
pancreas | 5% | 0.12 | 16 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 5% | 0.10 | 42 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 4% | 0.09 | 11 / 258 | 0% | 0 | 0 / 230 |
uterus | 4% | 0.11 | 7 / 170 | 0% | 0 | 0 / 459 |
lung | 4% | 0.08 | 22 / 578 | 0% | 0.00 | 2 / 1155 |
intestine | 4% | 0.11 | 37 / 966 | 0% | 0 | 0 / 527 |
spleen | 4% | 0.09 | 9 / 241 | 0% | 0 | 0 / 0 |
thymus | 4% | 0.06 | 24 / 653 | 0% | 0 | 0 / 605 |
esophagus | 4% | 0.11 | 52 / 1445 | 0% | 0 | 0 / 183 |
blood vessel | 4% | 0.07 | 48 / 1335 | 0% | 0 | 0 / 0 |
ovary | 3% | 0.07 | 6 / 180 | 0% | 0.00 | 1 / 430 |
breast | 3% | 0.06 | 15 / 459 | 0% | 0.00 | 1 / 1118 |
skin | 3% | 0.06 | 54 / 1809 | 0% | 0.00 | 1 / 472 |
stomach | 3% | 0.05 | 10 / 359 | 0% | 0.00 | 1 / 286 |
prostate | 2% | 0.05 | 6 / 245 | 0% | 0 | 0 / 502 |
adipose | 2% | 0.05 | 29 / 1204 | 0% | 0 | 0 / 0 |
heart | 2% | 0.04 | 18 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 0.05 | 16 / 803 | 0% | 0 | 0 / 0 |
liver | 2% | 0.04 | 4 / 226 | 0% | 0 | 0 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0009615 | Biological process | response to virus |
GO_0002250 | Biological process | adaptive immune response |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0098586 | Biological process | cellular response to virus |
GO_0042100 | Biological process | B cell proliferation |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0051607 | Biological process | defense response to virus |
GO_0033141 | Biological process | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO_0002323 | Biological process | natural killer cell activation involved in immune response |
GO_0030183 | Biological process | B cell differentiation |
GO_0002286 | Biological process | T cell activation involved in immune response |
GO_0006959 | Biological process | humoral immune response |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005132 | Molecular function | type I interferon receptor binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IFNA17 |
Protein name | Interferon alpha-17 (IFN-alpha-17) (Interferon alpha-88) (Interferon alpha-I') (LeIF I) (Interferon alpha-T) |
Synonyms | |
Description | FUNCTION: Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. . |
Accessions | P01571 ENST00000413767.2 |